drugset / Trial / NCT04551599

A Study of the Effects of Food and Age on Danicopan

NCT04551599

Phase 1 Completed 27 enrolled Alexion Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This will be an open-label, 2-part study. Part 1 will be a randomized, 2-sequence, 2-period crossover, food-effect study in healthy young adult participants. Part 2 will be a 1-period age-effect study in healthy elderly male participants.

Timeline

Start
2020-02-21
Primary completion
2021-02-03
Completion
2021-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Danicopan Small molecule 200 mg Oral

Indications

No indication recorded.